Home › Companies › INTELLIA THERAPEUTICS INC. › 2024-2025

INTELLIA THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and INTELLIA THERAPEUTICS INC.’s Form 8-K, filed 2025-06-12 (Item 5.07 on EDGAR). Page generated 04 October 2026.

12Reported items
307Asset managers
2,062Fund votes
2025-06-11Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore INTELLIA THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by INTELLIA THERAPEUTICS INC.

These tallies are INTELLIA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

INTELLIA THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-06-11
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: William Chase	62,680,787	1,430,529	402,742	--	18,310,157	Majority: yes
Elect Director: Georgia Keresty, Ph.D., M.P.H.	52,181,824	11,931,333	400,901	--	18,310,157	Majority: yes
Elect Director: John M. Leonard, M.D.	62,998,385	1,440,686	74,987	--	18,310,157	Majority: yes

Source: INTELLIA THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-12 — read the filing on EDGAR.

How asset managers voted at the INTELLIA THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 307 asset managers that disclosed a INTELLIA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of INTELLIA THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOs").

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-11.

Combines 11 wordings of this item as funds reported it.

67% fund support · no official result

FOR 67%AGAINST 33%

The 287 asset managers below cast 67% of the shares they voted on this item FOR (41,556,969 for, 20,876,770 against).

FOR: 41,556,969 (66.5%)AGAINST: 20,876,770 (33.4%)ABSTAIN: 11,379 (0.0%)NOT VOTED: 4,703 (0.0%)NO VOTE: 950 (0.0%)

Largest asset managers voting on “Approval, on a non-binding advisory basis, of the compensation of our named executive officers ("NEOs").” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	11,989,593	0	For
Vanguard	10,416,917	8,557	For
Capital Group	0	7,558,848	Against
State Street	6,211,896	59,422	For
BlackRock	5,532,060	49,187	For
Nikko Asset Management Co., Ltd.	0	2,825,361	Against
Contrarius Group Holdings Ltd	2,134,143	0	For
Charles Schwab	0	1,572,119	Against
Morgan Stanley	1,572,723	0	For
Two Sigma	0	1,059,012	Against
STIFEL NICOLAUS & CO INC \MO\	0	804,771	Against
Fidelity	711,388	82,601	For
Northern Trust	0	534,505	Against
Casdin Capital, LLC	0	469,463	Against
ARMISTICE CAPITAL, LLC	456,000	0	For
ARK Investment Management LLC	391,802	0	For
UBS	0	388,474	Against
American Century	0	378,108	Against
GEODE CAPITAL MANAGEMENT, LLC	357,542	0	For
Citadel	349,082	0	For
Equitable	214,503	100,800	For
Vestmark Advisory Solutions, Inc.	0	311,483	Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC	0	277,603	Against
Nuveen	0	272,297	Against
AMERICAN BEACON FUNDS	257,736	0	For

Showing the 25 largest of 287 asset managers. See all 287 in the interactive database.

2. A non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our NEOs.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-11.

Combines 5 wordings of this item as funds reported it.

28% fund support · no official result

ONE YEAR 53.6%1 YEAR 40%

The 283 asset managers below cast 28% of the shares they voted on this item FOR (12,477 for, 32,189 against).

FOR: 12,477 (0.0%)AGAINST: 32,189 (0.1%)ABSTAIN: 11,532 (0.0%)ONE YEAR: 33,397,933 (53.6%)1 YEAR: 24,764,027 (39.7%)1YR: 3,779,424 (6.1%)THREE YEARS: 279,960 (0.4%)3 YEARS: 63,173 (0.1%)2 YEARS: 9,383 (0.0%)1-YEAR: 7,780 (0.0%)NOT VOTED: 3,753 (0.0%)1YEAR: 160 (0.0%)1: 50 (0.0%)1.0: 0 (0.0%)3.0: 0 (0.0%)2.0: 0 (0.0%)

Largest asset managers voting on “A non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our N” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
ARK ETF Trust	0	0	0	0	1 Year
Vanguard	0	0	0	0	One Year
Capital Group	0	0	0	0	1Yr
State Street	0	0	0	0	One Year
BlackRock	0	0	0	0	1 Year
Nikko Asset Management Co., Ltd.	0	0	0	0	One Year
Contrarius Group Holdings Ltd	0	0	0	0	1 Year
Charles Schwab	0	0	0	0	1 Year
Morgan Stanley	0	0	0	0	One Year
Two Sigma	0	0	0	0	One Year
STIFEL NICOLAUS & CO INC \MO\	0	0	0	0	One Year
Fidelity	0	0	0	0	One Year
Northern Trust	0	0	0	0	1 Year
Casdin Capital, LLC	0	0	0	0	One Year
ARMISTICE CAPITAL, LLC	0	0	0	0	1 Year
ARK Investment Management LLC	0	0	0	0	1 Year
UBS	0	0	0	0	One Year
American Century	0	0	0	0	One Year
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	One Year
Citadel	0	0	0	0	One Year
Equitable	0	0	0	0	One Year
Vestmark Advisory Solutions, Inc.	0	0	0	0	1 Year
PARAMETRIC PORTFOLIO ASSOCIATES LLC	0	0	0	0	One Year
Nuveen	0	0	0	0	One Year
AMERICAN BEACON FUNDS	0	0	0	0	One Year

Showing the 25 largest of 283 asset managers. See all 283 in the interactive database.

3. APPROVAL OF THE INTELLIA THERAPEUTICS, INC. 2025 EQUITY INCENTIVE PLAN.

OTHER

Meeting held 2025-06-11.

Combines 2 wordings of this item as funds reported it.

94% fund support · no official result

FOR 94%

The 68 asset managers below cast 94% of the shares they voted on this item FOR (33,144,651 for, 2,038,234 against).

FOR: 33,144,651 (94.2%)AGAINST: 2,038,234 (5.8%)ABSTAIN: 0 (0.0%)

Largest asset managers voting on “APPROVAL OF THE INTELLIA THERAPEUTICS, INC. 2025 EQUITY INCENTIVE PLAN.” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
ARK ETF Trust	11,989,593	0	For
Vanguard	10,154,292	844	For
Capital Group	3,779,424	0	For
BlackRock	2,611,991	0	For
State Street	2,257,875	3,602	For
Charles Schwab	0	785,946	Against
Fidelity	539,171	0	For
Morgan Stanley	376,020	0	For
Equitable	315,303	0	For
AMERICAN BEACON FUNDS	257,736	0	For
TIAA	255,838	0	For
American Century	0	188,987	Against
Bridge Builder Trust	46,350	75,060	Against
JPMorgan	110,328	0	For
Global X	0	108,947	Against
Victory Capital	0	105,749	Against
Dimensional	0	98,361	Against
Lincoln Financial	74,200	11,780	For
QUANTITATIVE MASTER SERIES LLC	83,339	0	For
AIG/SunAmerica	0	71,235	Against
Direxion Shares ETF Trust	0	64,202	Against
Thrivent	0	62,564	Against
Brighthouse	29,848	27,391	For
ProShares	0	56,826	Against
SIT MUTUAL FUNDS INC	0	55,400	Against

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

4. Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Georgia Keresty, Ph.D., M.P.H.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-11.

Combines 5 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST 19%

FOR: 52,181,824AGAINST: 11,931,333

INTELLIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Georgia Keresty, Ph.D., M.P.H.”): 52,181,824 for, 11,931,333 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,539,685 outstanding shares: 50.4% for, 12% against (62% of the company cast a for/against vote).

The 64 asset managers below cast 96% of the shares they voted on this item FOR (33,764,684 for, 1,407,180 against).

FOR 96%

FOR: 33,764,684 (96.0%)AGAINST: 1,407,180 (4.0%)ABSTAIN: 9,714 (0.0%)

Largest asset managers voting on “Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting o” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
ARK ETF Trust	11,989,593	0	0	For
Vanguard	10,154,292	844	0	For
Capital Group	3,779,424	0	0	For
BlackRock	2,611,991	0	0	For
State Street	2,258,618	2,859	0	For
Charles Schwab	785,946	0	0	For
Fidelity	539,171	0	0	For
Morgan Stanley	376,020	0	0	For
Equitable	214,503	100,800	0	For
AMERICAN BEACON FUNDS	257,736	0	0	For
TIAA	255,838	0	0	For
American Century	0	188,987	0	Against
Bridge Builder Trust	46,350	75,060	0	Against
JPMorgan	110,328	0	0	For
Global X	0	108,947	0	Against
Victory Capital	0	105,749	0	Against
Dimensional	0	98,361	0	Against
Lincoln Financial	74,200	11,780	0	For
QUANTITATIVE MASTER SERIES LLC	83,339	0	0	For
AIG/SunAmerica	0	71,235	0	Against
Direxion Shares ETF Trust	0	64,202	0	Against
Thrivent	0	62,564	0	Against
Brighthouse	20,134	27,391	9,714	Against
ProShares	0	56,826	0	Against
SIT MUTUAL FUNDS INC	0	55,400	0	Against

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

5. Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: John M. Leonard, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-11.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 62,998,385AGAINST: 1,440,686

INTELLIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: John M. Leonard, M.D.”): 62,998,385 for, 1,440,686 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,539,685 outstanding shares: 61% for, 1% against (62% of the company cast a for/against vote).

The 64 asset managers below cast 99.2% of the shares they voted on this item FOR (34,920,552 for, 251,312 against).

FOR 99.2%

FOR: 34,920,552 (99.3%)AGAINST: 251,312 (0.7%)ABSTAIN: 9,714 (0.0%)

Largest asset managers voting on “Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting o” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
ARK ETF Trust	11,989,593	0	0	For
Vanguard	10,155,136	0	0	For
Capital Group	3,779,424	0	0	For
BlackRock	2,611,991	0	0	For
State Street	2,261,477	0	0	For
Charles Schwab	785,946	0	0	For
Fidelity	539,171	0	0	For
Morgan Stanley	376,020	0	0	For
Equitable	214,503	100,800	0	For
AMERICAN BEACON FUNDS	257,736	0	0	For
TIAA	255,838	0	0	For
American Century	188,987	0	0	For
Bridge Builder Trust	121,410	0	0	For
JPMorgan	110,328	0	0	For
Global X	108,947	0	0	For
Victory Capital	105,749	0	0	For
Dimensional	0	98,361	0	Against
Lincoln Financial	81,141	4,839	0	For
QUANTITATIVE MASTER SERIES LLC	83,339	0	0	For
AIG/SunAmerica	71,235	0	0	For
Direxion Shares ETF Trust	64,202	0	0	For
Thrivent	62,564	0	0	For
Brighthouse	47,525	0	9,714	For
ProShares	56,826	0	0	For
SIT MUTUAL FUNDS INC	55,400	0	0	For

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

6. Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: William Chase

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-11.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 62,680,787AGAINST: 1,430,529

INTELLIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: William Chase”): 62,680,787 for, 1,430,529 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 103,539,685 outstanding shares: 61% for, 1% against (62% of the company cast a for/against vote).

The 64 asset managers below cast 99.2% of the shares they voted on this item FOR (34,917,067 for, 254,797 against).

FOR 99.2%

FOR: 34,917,067 (99.2%)AGAINST: 254,797 (0.7%)ABSTAIN: 9,714 (0.0%)

Largest asset managers voting on “Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting o” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
ARK ETF Trust	11,989,593	0	0	For
Vanguard	10,155,136	0	0	For
Capital Group	3,779,424	0	0	For
BlackRock	2,611,991	0	0	For
State Street	2,261,477	0	0	For
Charles Schwab	785,946	0	0	For
Fidelity	539,171	0	0	For
Morgan Stanley	376,020	0	0	For
Equitable	214,503	100,800	0	For
AMERICAN BEACON FUNDS	257,736	0	0	For
TIAA	255,838	0	0	For
American Century	188,987	0	0	For
Bridge Builder Trust	121,410	0	0	For
JPMorgan	110,328	0	0	For
Global X	108,947	0	0	For
Victory Capital	105,749	0	0	For
Dimensional	0	98,361	0	Against
Lincoln Financial	81,141	4,839	0	For
QUANTITATIVE MASTER SERIES LLC	83,339	0	0	For
AIG/SunAmerica	71,235	0	0	For
Direxion Shares ETF Trust	64,202	0	0	For
Thrivent	62,564	0	0	For
Brighthouse	47,525	0	9,714	For
ProShares	56,826	0	0	For
SIT MUTUAL FUNDS INC	55,400	0	0	For

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

7. RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATED

Meeting held 2025-06-11.

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 64 asset managers below cast 99.9% of the shares they voted on this item FOR (35,171,179 for, 685 against).

FOR: 35,171,179 (100.0%)AGAINST: 685 (0.0%)ABSTAIN: 9,714 (0.0%)

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
ARK ETF Trust	11,989,593	0	0	For
Vanguard	10,155,136	0	0	For
Capital Group	3,779,424	0	0	For
BlackRock	2,611,991	0	0	For
State Street	2,261,364	113	0	For
Charles Schwab	785,946	0	0	For
Fidelity	539,171	0	0	For
Morgan Stanley	376,020	0	0	For
Equitable	315,303	0	0	For
AMERICAN BEACON FUNDS	257,736	0	0	For
TIAA	255,838	0	0	For
American Century	188,987	0	0	For
Bridge Builder Trust	121,410	0	0	For
JPMorgan	110,328	0	0	For
Global X	108,947	0	0	For
Victory Capital	105,749	0	0	For
Dimensional	98,361	0	0	For
Lincoln Financial	85,980	0	0	For
QUANTITATIVE MASTER SERIES LLC	83,339	0	0	For
AIG/SunAmerica	71,235	0	0	For
Direxion Shares ETF Trust	64,202	0	0	For
Thrivent	62,564	0	0	For
Brighthouse	47,525	0	9,714	For
ProShares	56,826	0	0	For
SIT MUTUAL FUNDS INC	55,400	0	0	For

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

8. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-11.

63% fund support · no official result

FOR 63%AGAINST 37%

The 8 asset managers below cast 63% of the shares they voted on this item FOR (415,021 for, 240,264 against).

FOR: 415,021 (63.3%)AGAINST: 240,264 (36.7%)ABSTAIN: 45 (0.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
JPMorgan	415,021	0	0	For
Granahan Investment Management, LLC	0	232,320	0	Against
FORUM FUNDS II	0	6,790	0	Against
Desjardins Global Asset Management Inc.	0	907	0	Against
TD Waterhouse Canada Inc.	0	200	0	Against
Investment Partners Asset Management, Inc.	0	0	45	Abstain
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	0	27	0	Against
Carmel Capital Management L.L.C.	0	20	0	Against

9. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-11.

— fund support · no official result

ONE YEAR 64%1 YEAR 36%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 416,128 (63.5%)1 YEAR: 239,110 (36.5%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
JPMorgan	0	0	0	0	One Year
Granahan Investment Management, LLC	0	0	0	0	1 Year
FORUM FUNDS II	0	0	0	0	1 Year
Desjardins Global Asset Management Inc.	0	0	0	0	One Year
TD Waterhouse Canada Inc.	0	0	0	0	One Year

10. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-11.

Combines 2 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 3 asset managers below cast 99.8% of the shares they voted on this item FOR (176,625 for, 255 against).

FOR: 176,625 (99.9%)AGAINST: 255 (0.1%)

Largest asset managers voting on “14A Executive Compensation” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
Orchard Capital Management, LLC	157,236	0	For
Green Alpha Advisors, LLC	19,089	0	For
Focus Partners Wealth	300	255	For

11. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-11.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 92%8%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (6,363 for, 0 against).

FOR: 6,363 (92.0%)1 YEAR: 555 (8.0%)

Largest asset managers voting on “14A Executive Compensation Vote Frequency” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Green Alpha Advisors, LLC	6,363	0	0	0	For
Focus Partners Wealth	0	0	0	0	1 Year

12. Approve, on a non-binding advisory basis, the compensation of the named executive officers

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-06-12 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,166 for, 0 against).

FOR: 1,166 (100.0%)

Largest asset managers voting on “Approve, on a non-binding advisory basis, the compensation of the named executive officers” at INTELLIA THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Ipswich Investment Management Co., Inc.	793	0	0	0	For
COLDSTREAM CAPITAL MANAGEMENT INC	373	0	0	0	For

Largest INTELLIA THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of INTELLIA THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 103,539,685 shares outstanding at the time of that meeting.

Top INTELLIA THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	ARK ETF Trust	11.58%
2	Vanguard	10.07%
3	Capital Group	7.30%
4	State Street	6.06%
5	BlackRock	5.39%
6	Nikko Asset Management Co., Ltd.	2.73%
7	Contrarius Group Holdings Ltd	2.06%
8	Charles Schwab	1.52%
9	Morgan Stanley	1.52%
10	Two Sigma	1.02%

Reported INTELLIA THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

INTELLIA THERAPEUTICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
ARK Investment Management LLC	13.72%	13G
Vanguard Group	10.38%	13F
BlackRock	10.20%	13F
Vanguard Portfolio Management	6.05%	13G
State Street	4.36%	13F
Morgan Stanley	3.67%	13F
Citadel Advisors	2.99%	13F
Goldman Sachs	2.36%	13F
Two Sigma	1.92%	13F
Dimensional Fund Advisors	1.90%	13F

Percentages above are of 103,539,685 shares outstanding, as reported by INTELLIA THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from INTELLIA THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At INTELLIA THERAPEUTICS INC.'s shareholder meeting held 2025-06-11, in the 2024-2025 proxy season, 307 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,062 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. INTELLIA THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval, on a non-binding advisory basis, of the compensation of our named executive officers… — the reporting funds cast 67% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

INTELLIA THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.